Evidence map›Paper›PMID 37388604›Full record

ArticleCureus2023

Omicron-Induced Immune Thrombocytopenia: A Case Report.

Haneen A Toba, Mohammad Abu-Tineh, Awni Alshurafa, Khalid Ahmed, Baian Mohammed, Mahmoud M Altayyan, Mohammed Abdulgayoom, Mohamed A Yassin

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haneen A TobaDepartment of Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Mohammad Abu-TinehDepartment of Medical Oncology, Hematology and Bone Marrow Transplant Section, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QAT.
Awni AlshurafaDepartment of Medical Oncology, Hematology and Bone Marrow Transplant Section, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QAT.
Khalid AhmedDepartment of Medical Oncology, Hematology and Bone Marrow Transplant Section, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QAT.
Baian MohammedDepartment of Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Mahmoud M AltayyanDepartment of Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Mohammed AbdulgayoomDepartment of Internal Medicine, Hamad General Hospital, Doha, QAT.
Mohamed A YassinDepartment of Hematology and Oncology, Hamad General Hospital, Doha, QAT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 is a systemic infection that significantly impacts the hematopoietic system and hemostasis. Among the hematological manifestations described, severe and symptomatic thrombocytopenia is rare. Immune thrombocytopenia (ITP), also known as idiopathic thrombocytopenic purpura or immune thrombocytopenic purpura, is an acquired thrombocytopenia caused by autoantibodies against platelet antigens. It is one of the more common causes of thrombocytopenia in otherwise asymptomatic adults. Here, we report the case of a patient who developed ITP after a severe acute respiratory syndrome coronavirus 2 infection to highlight the rarer hematological manifestations of the disease and the changes in treatment.

Indexed as

covid-19itpivigsteroidsthrombocytopenia

Identifiers

PMID37388604
PMCPMC10306311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.